C-SQUARED PHARMA LTD

Overview

C-SQUARED PHARMA LTD is an active pharmaceutical ingredient (API) supplier with 12 active FDA Type II Drug Master Files, covering ATROPINE SULFATE USP; BENOXINATE HYDROCHLORIDE; BIMATOPROST; BRIMONIDINE TARTRATE; CYCLOPENTOLATE HYDROCHLORIDE; DIGOXIN.

API / Drug Master Files

C-SQUARED PHARMA LTD holds 12 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• TIMOLOL MALEATEActive2025-12-18
• BENOXINATE HYDROCHLORIDEActive2025-03-07
• NAPHAZOLINE HYDROCHLORIDEActive2024-11-28
• TROPICAMIDEActive2023-01-31
• CYCLOPENTOLATE HYDROCHLORIDEActive2021-10-22
• HOMATROPINE HYDROBROMIDEActive2020-04-28
• HOMATROPINE METHYLBROMIDE USPActive2016-12-16
• ATROPINE SULFATE USPActive2016-09-09
• BIMATOPROSTActive2012-03-19
• DIGOXINActive2010-12-02
• LATANOPROST USPActive2010-02-13
• BRIMONIDINE TARTRATEActive2009-01-28

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to C-SQUARED PHARMA LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.